UnitedHealth Stock’s Biggest Risk Sits In The Commercial Book
Medicare’s improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.
UnitedHealth (UNH) shares are up about 34% over the past year, ahead of the S&P 500’s 21%, on a recovery in margins the company is only partway through. Two of the moving parts in that recovery are pulling in opposite directions, and the one that is deteriorating has no date on its fix.
The Top Line Went Flat On Purpose
Year-over-year revenue growth, after topping 12% for two straight quarters, has stepped down over the last two periods to 2.0% and now 0.4%, and the company has intentionally prioritized margin discipline over top-line volume. UnitedHealthcare expects full-year 2026 Medicare Advantage enrollment to decline by approximately 1.1 million through benefit adjustments and selective changes in market participation aimed at margin stability. On $450.1 billion of trailing-twelve-month revenue, that is a business trading size for profitability, and with the top line flat every dollar of earnings recovery now has to come out of cost.
Medicare Is Improving Without The Trend Inflecting
Medicare is where the repair is working. Management expects the 2026 Medicare medical cost trend to come in below its initial estimate of around 10%, pointing first to its own benefit design, care management models and network curation. Management also names a more favorable respiratory season and weather patterns alongside them. The company-wide reported second-quarter medical care ratio of 86.7% was itself helped by $860 million of net favorable prior period medical development, the majority of which was in-year development. Management is explicit that the softer Medicare trend is not an inflection point.
An Ineffective Arbitration Process Is Adding Cost
The commercial side is going the other way. Commercial medical cost trend is running modestly above the 11% the company had been seeing. The independent resolution process under the No Surprises Act, which applies only to commercial plans, is adding 50 basis points or so of incremental trend in 2026 and now totals at least 100 basis points of cost. The company’s management characterizes the process as inefficient, noting that dispute filings are heavily concentrated among a small number of provider groups. Add provider coding intensity in office visits and emergency departments, and full commercial margin recovery has been pushed past 2027. Margin repair on a timetable that keeps moving is a different proposition from the strong margins the Trefis High Quality Portfolio looks for in its holdings.
The Timetable Is The Risk, Not The Direction
Adjusted earnings per share guidance for 2026 was raised to a range of $19.50 to $20, and the price is not demanding on sales: the stock trades at $390.11, and its price-to-sales multiple sits about 21% of the way up its own ten-year range. UnitedHealth is still short of its own recent norm, with a company-wide operating margin of 4.8% against a three-year average of 7.1%. The number that settles the pace is the commercial trend: until it comes back below 11%, the recovery date keeps moving. The shares sit at about 89% of their 52-week high after a 2.6% return over the past three months. The market is not braced for a slip: implied volatility is at 29, the 22nd percentile of its trailing one-year range, so the one-year move the options market is pricing is at the low end of what it has priced over the past year.
Owning A Turnaround Means Owning Its Timetable
Timetables slip, and the position wears it when they do. Spreading that across a rules-based set of quality businesses is what the Trefis High Quality Portfolio is for. That portfolio has a track record of outpacing the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.